Earnings calls

Indoco Remedies concall ledger

Every earnings call for INDOCO — management tone, guidance, KPIs and promise tracking, quarter by quarter.

INDOCO · 4 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 07 May 2026Call held 07 May 2026

INDOCO Q4 FY26 Earnings Call Transcript & Analysis

Consolidated EBITDA497 millionStandalone EBITDA Margin14.7%

Consolidated EBITDA 497 million; Standalone EBITDA Margin 14.7%. Consolidated Net Revenues grew 18.8% YoY to INR 4,559 million.

Q3 FY26Published 03 Feb 2026Call held 03 Feb 2026

Consolidated EBITDA315 million+163% YoYConsolidated EBITDA Margin7.3%

Consolidated EBITDA 315 million (+162% YoY); Consolidated EBITDA Margin 7.3%. Consolidated Net Revenues grew 7.9% YoY to INR 4,343 million.

Q2 FY26Published 06 Nov 2025Call held 06 Nov 2025

Consolidated EBITDA₹43.1 cr+7% YoYConsolidated EBITDA Margin9.1%

Consolidated EBITDA ₹43 cr (+7% YoY); Consolidated EBITDA Margin 9.1% (−0% YoY). Consolidated net revenues grew 9.5% YoY to ₹471.8 crores.

Q4 FY25Published 24 Jul 2025Call held 24 Jul 2025

Consolidated EBITDA Margin4.1%

Consolidated EBITDA Margin 4.1%. Consolidated net revenues grew 11.77% QoQ to ₹4,291 million.